Advances in Cancer Therapies and Diagnostics

 LIVE Symposium

March 18-19, 2025
11:00 AM - 3:00 PM ET

Cutting-edge research and innovations are transforming the cancer landscape. From genome editing to nanotechnologies, scientists across disciplines continue to push the envelope of oncology breakthroughs, leading to translational diagnostic discoveries and treatment advances.

In this two-day symposium brought to you by The Scientist, researchers will highlight basic, preclinical, and clinical cancer research involving new diagnostics and therapeutics.

Topics to be covered 

• Cell-based therapeutic engineering with new biomaterials
• How genetic variation shapes normal physiology and cancer
• Using prime and base editing technologies to investigate cancer mutations
• Therapeutic applications of epigenetic regulation in cancer biology
• Computational approaches that dissect therapeutic resistance and susceptibility
• Elucidating the functions of receptor crosstalk in triple-positive breast cancer
• Precision molecular diagnostics for pediatric malignancies

View Agenda

Francisco Sánchez-Rivera, PhD Eisen & Chang Career Development Assistant Professor, Biology Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology

David Liu, MD, MPH Assistant Professor, Medicine Dana-Farber Cancer Institute, Harvard Medical School Associate Member, Broad Institute of Harvard and MIT

Omid Veiseh, PhD Professor, Bioengineering CPRIT Scholar in Cancer Research Director, Rice Biotech Launch Pad Rice University

Lei (Stanley) Qi, PhD Associate Professor, Bioengineering Stanford University

Rebecca B. Riggins, PhD Associate Professor of Oncology,  Georgetown Lombardi Comprehensive Cancer Center

Jong-Sun Lee, PhD Assistant Instructor Joshua Mendell Lab UT Southwestern Medical Center

Elaine Mardis, PhD Co-executive Director The Institute for Genomic Medicine at Nationwide Children’s Hospital Professor of Pediatrics The Ohio State University College of Medicine

Tom Charlesworth, PhD Director Market Strategy and Corporate Development biomodal

Mouadh Barbirou, MSc, PhD Research Associate and Circulating Tumor Cell Core Manager Sidney Kimmel Cancer Center, Thomas Jefferson University

Platinum Sponsor

Gold Sponsors

Silver Sponsors